
Loading, please wait...

Loading, please wait...

Yes, surgical treatment for cervical spondylotic myelopathy significantly improves headache symptoms in most patients. Research shows a substantial reduction in headache intensity that persists for at least five years postoperatively.
No, data indicates that both ACDF and PCLF are equally effective at providing relief. The choice between an anterior or posterior approach should depend on the patient's specific spinal pathology rather than the goal of headache resolution.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Bhowmick DA et al. Does surgical approach affect headache relief in patients undergoing cervical fusion for subaxial cervical spondylotic myelopathy? A Spine CORe™ analysis of QOD data. Neurosurg Focus. 2026 May 01. doi: 10.3171/2025.12.FOCUS25934. PMID: 42066371.
Lombardi JM, Vivas AC, Gornet MF, et al. The Effect of ACDF or Arthroplasty on Cervicogenic Headaches: A Post Hoc Analysis of a Prospective, Multicenter Study With 10-Year Follow-up. Clin Spine Surg. 2020;33(9):339-344.
Yang L, Li Y, Dai C, Peng B. Anterior cervical decompression and fusion surgery for cervicogenic headache: A multicenter prospective cohort study. Front Surg. 2022;9:1010375.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study analyzes whether ACDF or PCLF provides better long-term headache relief for patients with cervical spondylotic myelopathy....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today